EX-32.1 7 tnya-ex32_1.htm EX-32.1

Exhibit 32.1

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Faraz Ali, M.B.A., certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, (1) the Annual Report on Form 10-K of Tenaya Therapeutics, Inc. for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|  | /s/ Faraz Ali, M.B.A.
|  | Faraz Ali, M.B.A.
|  | Chief Executive Officer and Director (Principal Executive Officer)
|  | Date: March 23, 2022

I, Leone D. Patterson, M.B.A., certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, (1) the Annual Report on Form 10-K of Tenaya Therapeutics, Inc. for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

|  | /s/ Leone D. Patterson, M.B.A.
|  | Leone D. Patterson, M.B.A.
|  | Chief Financial and Business Officer (Principal Financial and Accounting Officer)
|  | Date: March 23, 2022